Rigel Pharmaceuticals Inc - Company Profile
Powered by 
All the sales intelligence you need on Rigel Pharmaceuticals Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Rigel Pharmaceuticals Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Rigel Pharmaceuticals Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Rigel Pharmaceuticals Inc (Rigel) is a biotechnology company that focuses on discovering, developing and providing novel therapies for the treatment of cancer and hematologic disorders. Improved operational performance, focused research and development activities, and product portfolio of the company are its major strengths, even as huge dependency on collaborations and licensing agreements remains a major cause for concern. Intense competition, stringent regulations, market dynamics and economic uncertainty could harm Rigel’s business. However, strategic agreement, innovation in hematologic therapies, and product pipeline could present opportunities for the company.
Strengths
Weaknesses
Opportunities
Threats
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer